FENNEC PHARMACEUTICALS INC. — Director's Dealing 2023

Jul 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2023-07-06

Reporting Person: RALLIS CHRIS A (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-07-06	Common Shares	S	2207	$8.47	Disposed	28826	Direct
2023-07-06	Common Shares	M	5280	$0.96	Acquired	34106	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-07-06	Common Shares	$0.96	M	5208	Disposed	2023-08-06	Options (5208)	Direct

Footnotes

F1: Shares sold to satisfy tax obligation on option exercise.

F2: Shares acquired through the exercise of an option contract with strike price of $0.96 and an expiration date of August 6, 2023.

F3: Represents options granted on August 6, 2013, with a strike price of $0.96 and expiration date of August 6, 2023.